首頁 > 市場調查報告書 > 醫療設備

泌尿科透析設備

市場調查報告書

商品編碼

2084781

血液透析膜市場：按材料、通量類型、最終用戶和地區分類。

Hemodialysis Membrane Market, By Material, By Flux Type, By End User, By Geography

出版日期: 2026年06月15日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，血液透析膜市場規模將達到 112 億美元，到 2033 年將達到 165 億美元。預計 2026 年至 2033 年的複合年成長率為 5.7%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	112億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.70%	2033年市場規模預測：	165億美元

血液透析膜市場是腎臟替代治療行業的重要組成部分，為末期腎功能衰竭（ESRD）和急性腎損傷患者的治療提供支持。血液透析膜透過過濾過濾血液中多餘的代謝廢物、液體和毒素，發揮人工腎臟的作用。它們採用纖維素、聚碸（PS）、聚醚碸（PES）和聚甲基丙烯酸甲酯（PMMA）等材料製成，產品具有不同的過濾性能和生物相容性。

該市場涵蓋高通量、低通量和中截留分子量的薄膜，這些薄膜能夠在清除毒素的同時保留必需蛋白質。隨著糖尿病和高血壓的日益普及以及全球人口老化，慢性腎臟病病例數量持續成長，導致血液透析治療需求不斷增加。膜技術的進步提高了毒素清除效率並抑制了發炎反應，從而改善了患者的治療效果，推動了已開發地區和發展中地區的市場成長。

市場動態

全球血液透析膜市場成長的主要驅動力是慢性腎臟病(CKD) 和末期腎功能衰竭(ESRD) 發生率的上升。醫療設施投資的增加、透析中心的擴建以及腎臟替代療法的普及，都推動了市場成長。此外，血液透析膜技術的進步，例如具有更高生物相容性和過濾能力的透析膜，也提高了治療效率和透析膜的普及率。

然而，該市場面臨許多限制因素，包括先進薄膜的高昂成本、開發中國家醫療費用支出的限制以及嚴格的監管準則。熟練的醫療保健專業人員短缺和透析基礎設施不足也阻礙了市場成長。儘管如此，中等截留膜的研發、家庭透析的普及、進入低度開發地區以及在患者監測和治療管理中應用數位化醫療解決方案，預計將為市場參與企業帶來充滿希望的機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球血液透析膜市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球血液透析膜市場」報告旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球血液透析膜市場分析中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

Fresenius Medical Care
Baxter International Inc.
Nipro Corporation
Asahi Kasei Medical Co., Ltd.
Braun Melsungen AG
Toray Medical Co., Ltd.
Nikkiso Co., Ltd.
JMS Co., Ltd.
WEGO Group
SB-KAWASUMI Laboratories, Inc.

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9632

Hemodialysis Membrane Market is estimated to be valued at USD 11.2 Bn in 2026 and is expected to reach USD 16.5 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 11.2 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.70%	2033 Value Projection:	USD 16.5 Bn

The hemodialysis membrane market is an integral component of the renal replacement therapy industry, assisting in the treatment of patients suffering from end-stage renal disease (ESRD) and acute kidney injury. Hemodialysis membranes function as artificial kidneys by removing excess waste products, fluid and toxins from the blood by selective filtration. These are created using materials, such as cellulose, polysulfone (PS), Polyethersulfone (PES), and Polymethyl Methacrylate (PMMA), to allow differing degrees of filtration and biocompatibility.

The market encompasses high-flux, low-flux and medium cut-off membranes that serve to enhance toxin removal while retaining essential proteins. Cases of chronic kidney disease have been steadily on the rise due to rising diabetes, hypertension and an aging global population. This contributes to the increased demand of hemodialysis treatment. Technological improvements in membranes allow better toxin clearance and lower inflammatory response leading to better patient outcomes, driving the growth of the market throughout both developing and developed regions.

Market Dynamics

The global hemodialysis membrane market is driven by rising incidence of chronic kidney disease (CKD) and end stage renal disease (ESRD). Rising investment in healthcare facilities, expansion of dialysis centers and easy availability of renal replacement therapy are boosting the market growth. Furthermore, technological advancements in hemodialysis membranes including high flux membranes with improved biocompatibility and filtering capability have been developed. This has contributed to increase treatment efficiency and improved adoption rate of the membranes.

However, a number of constraints are present in the market, such as high price of advanced membranes, restricted healthcare spending in the developing economies, and stringent regulatory guidelines. Dearth of skilled healthcare professionals and insufficient dialysis infrastructure is also hampering the market growth. Nevertheless, development of medium cut-off membrane, increase in home dialysis adoption, entry in underdeveloped regions, and use of digital health solutions in patient monitoring and treatment management are expected to provide lucrative opportunities for the market participants.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hemodialysis membrane market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fresenius Medical Care, Baxter International Inc., Nipro Corporation, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Toray Medical Co., Ltd., Nikkiso Co., Ltd., JMS Co., Ltd., WEGO Group, and SB-KAWASUMI Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hemodialysis membrane market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemodialysis membrane market

Market Segmentation

Material Insights (Revenue, USD Bn, 2021 - 2033)
Polysulfone (PS)
Polyethersulfone (PES)
Polymethyl Methacrylate (PMMA)
Cellulose-Based Membranes
Others
Flux Type Insights (Revenue, USD Bn, 2021 - 2033)
High-Flux Membranes
Low-Flux Membranes
End User Insights (Revenue, USD Bn, 2021 - 2033)
Dialysis Centers
Hospitals
Home Healthcare Settings
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Fresenius Medical Care
Baxter International Inc.
Nipro Corporation
Asahi Kasei Medical Co., Ltd.
Braun Melsungen AG
Toray Medical Co., Ltd.
Nikkiso Co., Ltd.
JMS Co., Ltd.
WEGO Group
SB-KAWASUMI Laboratories, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Hemodialysis Membrane Market, By Material
- Global Hemodialysis Membrane Market, By Flux Type
- Global Hemodialysis Membrane Market, By End User
- Global Hemodialysis Membrane Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Hemodialysis Membrane Market, By Material, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Polysulfone (PS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Polyethersulfone (PES)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Polymethyl Methacrylate (PMMA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cellulose-Based Membranes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Hemodialysis Membrane Market, By Flux Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
High-Flux Membranes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Low-Flux Membranes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Hemodialysis Membrane Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Dialysis Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Hemodialysis Membrane Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Flux Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Flux Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Flux Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Flux Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Flux Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Flux Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Fresenius Medical Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nipro Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Asahi Kasei Medical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Toray Medical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nikkiso Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
JMS Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WEGO Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SB-KAWASUMI Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies